References
- 1. J. R. Robinson, Introduction: semi-solid formulations for oral drug delivery, Bull. Tech. Gattefosse 89 (1996) 11-13.
- 2. A. K. Meena, D. V. Ratnam, G. Chandraiah, D. D. Ankola, P. R. Rao and M. N. Kumar, Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia, Lipids 43 (2008) 231-241; DOI: 10.1007/s11745-007-3142-5.10.1007/s11745-007-3142-5
- 3. D. V. Ratnam, G. Chandraiah, A. K. Meena, P. Ramarao and M. N. Kumar, The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorate hyperlipidemia in high fat diet fed rats, J. Nanosci. Nanotechnol. 9 (2009) 6741-6746.10.1166/jnn.2009.1461
- 4. C. W. Pouton, Effects of the inclusion of a model drug on the performance of self-emulsifying formulations, J. Pharm. Pharmacol. 37 (1985) Suppl. 12:1P; DOI: 10.1111/j.2042-7158.1985.tb14073.
- 5. C. W. Pouton, Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification, Int. J. Pharm. 27 (1985) 335-348; DOI: 10.1016/ 0378-5173(85)90081-X.
- 6. C. W. Pouton, Formulation of self-emulsifying drug delivery systems, Adv. Drug. Deliv. Rev. 25 (1997) 47-58; DOI: 10.1016/S0169-409X(96)00490-5.10.1016/S0169-409X(96)00490-5
- 7. H. Shen and M. Zhong, Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin, J. Pharm. Pharmacol. 58 (2006) 1183-1191; DOI: 10.1211/jpp.58.9.0004.10.1211/jpp.58.9.0004
- 8. N. H. Shah, M. T. Carvajal, C. I. Patel, M. H. Infeld and A. W. Malick, Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, Int. J. Pharm. 106 (1994) 15-23; DOI: 10.1016/0378-5173(94)90271-2.10.1016/0378-5173(94)90271-2
- 9. T. R. Kommuru, B. Gurley, M. A. Khan and I. K. Reddy, Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment, Int. J. Pharm. 212 (2001) 233-246; DOI: 10.1016/ S0378-5173(00)00614-1.
- 10. A. A. Kale and V. B. Patravale, Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine, AAPS Pharm. Sci. Tech. 9 (2008) 191-196; DOI: 10.1208/s12249-008-9037-9.10.1208/s12249-008-9037-9
- 11. J. I. Tang, J. Sun and Z. G. He, Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs, Curr. Drug Therapy 2 (2007) 85-93.
- 12. P. Gao, B. D. Rush, W. P. Pfund, T. Huang, J. M. Bauer W. Morozowich, M. S. Kuo and M. J. Hageman, Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability, J. Pharm. Sci. 87 (2003) 2386-2398; DOI: 10.1002/jps.10511.10.1002/jps.10511
- 13. G. C. Cook, Use of benzimidazole chemotherapy in human helminthiases: Indications and efficacy, Parasitol. Today 6 (1990) 133-136; DOI: 10.1016/0169-4758(90)90232-S.10.1016/0169-4758(90)90232-S
- 14. E. Galia, J. Horton and J. B. Dressman, Albendazole generics: a comparative in vitro study, Pharm. Res. 16 (1999) 1871-1875; DOI: 10.1023/A:1018907527253.10.1023/A:1018907527253
- 15. I. M. Rigter, H. G. Schipper, R. P. Koopmans, H. J. M. Van Kan, H. W. Frijlink, P. A. Kager and H. J. Guchelaar, Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers, Antimicrob. Agents Chemother. 48 (2004) 1051-1054; DOI: 10.1128/ AAC. 48.3. 1051-1054.2004.
- 16. C. T. Dollery, Albendazole, in Therapeutic Drugs, 2nd ed., Churchill Livingstone, Edinburgh 1999, pp. 184-188.
- 17. J. J. García, F. Bolas and J. J. Torrado, Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole, Int. J. Pharm. 250 (2003) 351-358; DOI: 10.1016/S0378-5173(02)00559-8.10.1016/S0378-5173(02)00559-8
- 18. S. Torrado, S. Torrado, R. Cadorniga and J. J. Torrado, Formulation parameters of albendazole solution, Int. J. Pharm. 140 (1996) 45-50; DOI: 10.1016/0378-5173(96)04545-0.10.1016/0378-5173(96)04545-0
- 19. S. Torrado, M. L. López, G. Torrado, F. Bolás, S. Torrado and R. Cadórniga, A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation, Int. J. Pharm. 156 (1997) 181-187; DOI: 10.1016/S0378-5173(97)00204-4.10.1016/S0378-5173(97)00204-4
- 20. P. A. Redondo, A. I. Alvarez, J. L. García, C. Villaverde and J. G. Prieto, Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats, Biopharm. Drug Dispos. 19 (1998) 65-70.10.1002/(SICI)1099-081X(199801)19:1<65::AID-BDD76>3.0.CO;2-8
- 21. H. Wen, R. R. New, M. Muhmut, J. H. Wang, Y. H. Wang, J. H. Zhang, Y. M. Shao and P. S. Craig, Pharmacology and efficacy of liposome entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine, Parasitology 113 (1996) 111-121; DOI: 10.1017/S003118200006635X.10.1017/S003118200006635X
- 22. S. Torrado, S. Torrado, J. J. Torrado and R. Cadórniga, Preparation, dissolution and characterization of albendazole solid dispersion, Int. J. Pharm. 140 (1996) 247-250; DOI: 10.1016/0378-5173(96)04586-3.10.1016/0378-5173(96)04586-3
- 23. M. L. Lopez, S. Torrado, S. Torrado, A. R. Martínez and F. Bolás, Improvement of albendazole efficacy against enteral, but not against parenteral stages of Trichinella spiralis by preparing solid dispersions in polyvinylpyrrolidone, Chemotherapy 43 (1997) 430-435; DOI: 10.1159/000239602.10.1159/000239602
- 24. R. Kalaiselvan, G. P. Mohanta, K. Kannan, P. K. Manna and R. Manavalan, Optimization of drug-polymer mixing ratio in albendazole-polyvinylpyrrolidone solid dispersion by moisture absorption studies, Acta. Pharm. Sci. 48 (2006) 141-151.
- 25. J. A. Castillo, J. Palomo-Canales, J. J. Garcia, J. L. Lastres, F. Bolas and J. J. Torrado, Preparation and characterization of albendazole β-cyclodextrin complexes, Drug. Dev. Ind. Pharm. 25 (1999) 1241-1248; DOI: 10.1081/DDC-100102294.10.1081/DDC-100102294
- 26. G. Piel, B. Evrard, T. Van Hees, G. Llabres and L. Delattre, Development of a parenteral and of an oral formulation of albendazole with cyclodextrins, STP. Pharma. Sci. 9 (1999) 257-260.
- 27. T. Mukherjee and F. M. Plakogiannis, Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole, J. Pharm. Pharmacol. 62 (2010) 1112-1120; DOI: 10.1111/j.2042-7158.2010.01149.x.10.1111/j.2042-7158.2010.01149.x
- 28. C. W. Pouton, Lipid formulations for oral administration of drugs: non- emulsifying, self-emulsifying and self-microemulsifying drug delivery systems, Eur. J. Pharm. Sci. 11 (2000) S93-S98; DOI: 10.1016/S0928-0987(00)00167-6.10.1016/S0928-0987(00)00167-6
- 29. V. Borhade, H. Nair and D. Hegde, Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus, AAPS Pharm. Sci. Tech. 9 (2008) 13-21; DOI: 10.1208/s12249-007-9014-8.10.1208/s12249-007-9014-8
- 30. K. Sharma, M. Kandaswamy, C. Mithra, A. K. Meena, S. Giri, S. Rajagopal and R. Mullangi, Highly sensitive LC-MS/MS-ESI method for simultaenous quantitation of albendazole and ricobendazole in rat plasma and its application to a rat pharmacokinetic study, Biomed. Chromatogr. 26 (2011) 247-255; DOI: 10.1002/bmc.1654.10.1002/bmc.165421633966
- 31. H. Jung, M. Hurtado, M. Sanchez, M. T. Medina and J. Sotelo, Clinical pharmacokinetics of albendazole in patients with brain cysticercosis, J. Clin. Pharmacol. 32 (1992) 28-31.10.1002/j.1552-4604.1992.tb03783.x1740534
- 32. J. Sotelo and H. Jung, Pharmacokinetic optimization of treatment of neurocysticercosis, Clin. Pharmacokinet. 34 (1998) 503-515.10.2165/00003088-199834060-000069646011